4.8 Article

Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch

Journal

NATURE GENETICS
Volume 38, Issue 11, Pages 1329-1334

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ng1894

Keywords

-

Funding

  1. Medical Research Council [G0400264] Funding Source: Medline
  2. NIDCR NIH HHS [P50-DE016215] Funding Source: Medline
  3. Wellcome Trust [064732, 066173] Funding Source: Medline
  4. Medical Research Council [G0400264] Funding Source: researchfish
  5. MRC [G0400264] Funding Source: UKRI

Ask authors/readers for more resources

The epidermis is a highly organized structure, the integrity of which is central to the protection of an organism(1). Development and subsequent maintenance of this tissue depends critically on the intricate balance between proliferation and differentiation of a resident stem cell population(1,2); however, the signals controlling the proliferation-differentiation switch in vivo remain elusive(3). Here, we show that mice carrying a homozygous missense mutation in interferon regulatory factor 6 (Irf6), the homolog of the gene mutated in the human congenital disorders Van der Woude syndrome and popliteal pterygium syndrome, have a hyperproliferative epidermis that fails to undergo terminal differentiation, resulting in soft tissue fusions. We further demonstrate that mice that are compound heterozygotes for mutations in Irf6 and the gene encoding the cell cycle regulator protein stratifin (Sfn; also known as 14-3-3 sigma) show similar defects of keratinizing epithelia. Our results indicate that Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch and that Irf6 and Sfn interact genetically in this process.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available